首页> 外文OA文献 >PCN22 AN ECONOMIC EVALUATION OF CAPECITABINE/CISPLATIN PLUS 5-FU/CISPLATIN REGIMENS IN TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN

【2h】

PCN22 AN ECONOMIC EVALUATION OF CAPECITABINE/CISPLATIN PLUS 5-FU/CISPLATIN REGIMENS IN TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN

机译：PCN22卡培他滨/西沙丁胺加5-FU /西沙丁胺方案治疗西班牙晚期胃癌的经济评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Darba J; Restovic G; Ramírez de Arellano A;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 3519 POSTER Cost of treating advanced gastric cancer (AGC) with capecitabine/cisplatin vs. 5-FU/cisplatin regimens: An economic evaluation from an Italian perspective [J] . G.Giuliani, A.Falcone, A.Cirrincione, European Journal of Cancer Supplements . 2007,第4期

机译：3519 POSTER卡培他滨/顺铂与5-FU /顺铂方案治疗晚期胃癌（AGC）的费用：从意大利角度进行的经济评估
2. A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II) [J] . Nishikawa Kazuhiro, Tsuburaya Akira, Yoshikawa Takaki, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：Capecitabine Plus顺铂的随机期II试验与S-1加顺铂作为晚期胃癌的一线治疗：Capecitabine Plus顺铂确定与S-1加上顺铂随机化PII试验（XParts II）
3. A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II) [J] . Nishikawa Kazuhiro, Tsuburaya Akira, Yoshikawa Takaki, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：Capecitabine Plus顺铂的随机期II试验与S-1加顺铂作为晚期胃癌的一线治疗：Capecitabine Plus顺铂确定与S-1加上顺铂随机化PII试验（XParts II）
4. The effect of chloroquine on the apoptosis induced by cisplatin in human gastric cancer BGC823 cells [C] . Zhenxun Jin, Lili Zhang, Yan Wang, International Conference on Materials Science and Computational Engineering . 2014

机译：氯喹对人胃癌BGC823细胞顺铂诱导凋亡的影响
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel cisplatin 5-FU (TCF) with epirubicin cisplatin 5-FU (ECF) [O] . Sanambar Sadighi, Mohammad Ali Mohagheghi, Ali Montazeri, 2006

机译：晚期胃癌患者的生活质量：比较多西他赛顺铂5-FU（TCF）与表柔比星顺铂5-FU（ECF）的随机试验
7. PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian Setting [O] . Curescu S., Stanculeanu D.L., Croitoru A., 2011

机译：卡培他滨/顺铂（XP）与5-Fu /顺铂（FP）方案在晚期罗马尼亚胃癌（AGC）治疗中的PCN104成本最小化分析（CMA）

PCN22 AN ECONOMIC EVALUATION OF CAPECITABINE/CISPLATIN PLUS 5-FU/CISPLATIN REGIMENS IN TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN

著录项

引文网络

相似文献

相关主题

期刊订阅